Researchers have found a way to overcome resistance to cancer drugs by blocking TGFβ1, a protein that helps tumors hide from the immune system. In a Phase I trial, the new antibody linavonkibart achieved objective responses in patients who had failed existing immunotherapies.

Published 2 hours ago
Source: reddit.com

Categories

science